Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00245) | |||||
---|---|---|---|---|---|
Name |
Estazolam
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
estazolam; 29975-16-4; Eurodin; ProSom; Nuctalon; Julodin; Esilgan; D 40TA; 8-Chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine; Estazolamum; D-40TA; Abbott-47631; 8-Chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine; UNII-36S3EQV54C; NSC 290818; U 33737; 36S3EQV54C; CHEBI:4858; NSC-290818; NCGC00168250-01; 8-Chloro-6-phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepine; Nemurel; Somnatrol; Cannoc; 4H-s-Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-phenyl-; 4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-6-phenyl-; 4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine, 8-chloro-6-phenyl-; Abbott 47631; Estazolamum [INN-Latin]; 53180-72-6; Estazolam [USAN:INN:JAN]; Prosom (TN); CCRIS 1955; EINECS 249-982-4; BRN 1220868; Estazolam civ; 8-Chloro-6-phenyl-4H-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine; DEA No. 2756; 8-Chloro-6-phenyl-4H-(1,2,4)triazolo-(4,3-a)(1,4)benzodiazepine; Eurodin; ProSom; 8-Chloro-6-phenyl-4H-s-triazolo(4,3-a)(1,4)benzodiazepine (IUPAC); DSSTox_CID_572; DSSTox_RID_75665; DSSTox_GSID_20572; SCHEMBL28766; MLS003899222; BIDD:GT0481; Estazolam (JP17/USP/INN); CHEMBL285674; GTPL7550; ZINC1370; DTXSID5020572; CDCHDCWJMGXXRH-UHFFFAOYSA-; Estazolam 0.1 mg/ml in Methanol; Estazolam 1.0 mg/ml in Methanol; 8-Chloro-6-phenyl-4H-2,3,5,10b-tetraaza-benzo[e]azulene; BCP13317; Tox21_112609; MFCD00867537; NSC290818; AKOS005064373; AB07556; DB01215; SMR000238168; CAS-29975-16-4; WLN: T B576 BN DNN HN GHJ IR& LG; C06981; D00311; A820132; Q-201071; Q3045264; 8-Chloro-6-phenyl-4H-s-triazolo[4,4]benzodiazepine; 4H-s-Triazolo[4,4]benzodiazepine, 8-chloro-6-phenyl-; Estazolam solution, drug standard, 100 mug/L in methanol; 8-chloro-6-phenyl-4H-s-triazolo [4,3-a][1,4] benzodiazepine; 8-chloro-6-phenyl-4H-s-triazolo-[4,3-a][1,4]benzodiazepine; Estazolam, United States Pharmacopeia (USP) Reference Standard; 4H-[1,4]Triazolo[4,3-a][1,4]benzodiazepine, 8-chloro-6-phenyl-; 8-Chloro-6-phenyl-4H-[1,4]triazolo[4,3-a][1,4]benzodiazepine; 8-chloranyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine; Estazolam solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material; 12-chloro-9-phenyl-2,4,5,8-tetraazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,8,11,13-hexaene
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Insomnia | ICD-11: 7A00 | [1] | ||
PubChem CID | |||||
Formula |
C16H11ClN4
|
||||
Canonical SMILES |
C1C2=NN=CN2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4
|
||||
InChI |
1S/C16H11ClN4/c17-12-6-7-14-13(8-12)16(11-4-2-1-3-5-11)18-9-15-20-19-10-21(14)15/h1-8,10H,9H2
|
||||
InChIKey |
CDCHDCWJMGXXRH-UHFFFAOYSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=3261"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 294.74 | Topological Polar Surface Area | 43.1 | |
XlogP | 1.7 | Complexity | 407 | ||
Heavy Atom Count | 21 | Rotatable Bond Count | 1 | ||
Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 3 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Estazolam 2 mg tablet | Click to Show/Hide the Full List of Formulation(s): 4 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Lactose monohydrate; Sodium benzoate; Docusate sodium; Fd&c red no. 40; Magnesium stearate; Aluminum oxide; Cellulose, microcrystalline; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Rebel Distributors | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [3] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [4] | |||
Docusate sodium | DIG Info | Solute carrier SLCO2B1 (Ki = 2.3 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Lactose monohydrate; Sodium benzoate; Docusate sodium; Fd&c red no. 40; Magnesium stearate; Microcrystalline cellulose; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Actavis Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [3] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [4] | |||
Docusate sodium | DIG Info | Solute carrier SLCO2B1 (Ki = 2.3 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 3 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Lactose monohydrate; Fd&c red no. 40; Fd&c yellow no. 6; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [4] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [4] | |||
Drug Formulation 4 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Lactose monohydrate; Fd&c red no. 40; Fd&c yellow no. 6; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Mayne Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 4.7 uM) | [2] | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Sunset yellow FCF | DIG Info | Solute carrier SLCO2B1 (Ki = 68.4 uM) | [4] | |||
Allura red AC dye | DIG Info | Solute carrier SLCO2B1 (Ki = 2.59 uM) | [4] | |||
Estazolam 1 mg tablet | Click to Show/Hide the Full List of Formulation(s): 2 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Lactose monohydrate; Sodium benzoate; Docusate sodium; Magnesium stearate; Microcrystalline cellulose; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Actavis Pharma | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [3] | |||
Docusate sodium | DIG Info | Solute carrier SLCO2B1 (Ki = 2.3 uM) | [2] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [5] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Stearic acid; Lactose monohydrate; Starch, corn
|
|||||
Dosage Form | Oral Tablet | |||||
Company | Mayne Pharma; Teva Pharmaceuticals | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Stearic acid | DIG Info | Phosphodiesterase 3A (IC50 = 3.1 uM) | [2] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.